LX 2931 - Lexicon Pharma
LX 2931 (LX3305) - Lexicon Pharma
Wedbush Securities LifeSciences Management Access Conference (Lexicon) - Aug 16, 2011 - LX2931 / Lexicon; Anticipated initiation of dose escalation PoC trial in RA patients in Q3 '11; Anticipated dose ranging study results for RA in H1 '12 
Anticipated dose ranging study data • Anticipated PoC study initiation None • Rheumatoid Arthritis
http://www.larvolonline.com/tlg/ccdb/LexiconWedbushSecuritiesLifeSciencesManagementAccessConferenceAug16th2011.pdf
 
Aug 16, 2011
 
 
ccd48371-e1ae-4299-98e0-822bd263d0ed.jpg